Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876

Elsherbeny, Mohamed H.; Ammar, Usama M.; Abdellattif, Magda H.; Abourehab, Mohammed A. S.; Abdeen, Ahmed; Ibrahim, Samah F.; Abdelrahaman, Doaa; Mady, Wessam; Roh, Eun Joo; Elkamhawy, Ahmed

Abstract

In the original publication [1], reference number 26 [2] was added by mistake. Thus, it was removed.

With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Citation

Elsherbeny, M. H., Ammar, U. M., Abdellattif, M. H., Abourehab, M. A. S., Abdeen, A., Ibrahim, S. F., Abdelrahaman, D., Mady, W., Roh, E. J., & Elkamhawy, A. (2024). Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876. Life, 14(4), 423. https://doi.org/10.3390/life14040423

• Journal Article Type: Other
• Acceptance Date: Dec 14, 2023
• Online Publication Date: Mar 22, 2024
• Publication Date: 2024
• Deposit Date: Mar 30, 2024
• Publicly Available Date: Apr 2, 2024
• Publisher: MDPI
• Peer Reviewed: Peer Reviewed
• Volume: 14
• Issue: 4
• Pages: 423
• DOI: https://doi.org/10.3390/life14040423
• Keywords: quinazoline; Aurora A; kinases; anticancer; molecular docking; cell cycle; apoptosis
• Public URL: http://researchrepository.napier.ac.uk/Output/3579849